Effective drug safety communications are pivotal in the post‐marketing surveillance of pharmaceuticals. Regulatory authorities utilise a range of communication tools—from formal letters to electronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback